1. SAT0371 Ustekinumab Treatment in Ankylosing Spondylits (AS) Patients Does not Modulate Effector CD4+ T Cell Frequencies Including TH17 Cells. (10th June 2014) Authors: Syrbe, U.; Conrad, K.; Wu, P.; Bacher, P.; Scheffold, A.; Poddubnyy, D.; Sieper, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗